Snoring and Sleep Apnea: Not Just Noise, But a Threat to Health
Snoring, often perceived as a harmless phenomenon, can be a precursor or symptom of a more serious condition—obstructive sleep apnea (OSA). OSA is characterized by repetitive episodes of complete or partial cessation of breathing during sleep, which leads to a decrease in blood oxygen levels and frequent awakenings. This sleep disorder not only impairs quality of life, but also significantly increases the risk of developing numerous chronic diseases.
Among the most common comorbidities in OSA are obesity, depression, and even neurological disorders [1]. In addition, sleep apnea is closely linked to cardiovascular problems. For example, nocturnal hypertension (elevated blood pressure at night) is a stronger predictor of cardiovascular events than daytime blood pressure and is common in patients with sleep disorders [2]. OSA is also associated with an increased risk of paroxysmal atrial fibrillation [8] and worsening glycemic control in people with diabetes [6].
It is important to note that some rare disorders, such as catatrenia (moaning during prolonged expiration), can be misdiagnosed as OSA or central sleep apnea. Accurate diagnosis of clinical and polysomnographic features is critical for proper treatment [1].
Diagnosis of Sleep Disorders: The Key to Effective Treatment
The basis for accurate diagnosis of sleep apnea is polysomnography (PSG)—a comprehensive sleep study that records various physiological parameters such as brain activity, eye movements, muscle activity, heart rate, breathing, and blood oxygen levels [1]. PSG not only confirms the presence of OSA, but also determines its severity and rules out other sleep disorders that may have similar symptoms.
When sleep apnea or other sleep-related breathing disorders, such as catatrenia, are suspected, synchronized audio-video recording during PSG can be extremely useful for differential diagnosis [1]. Proper diagnosis allows for selecting the most appropriate treatment strategy and avoiding incorrect approaches.
Traditional and Proven Treatment Methods
Among the treatment methods for sleep apnea, there are both long-established and innovative approaches.
-
CPAP Therapy
Continuous positive airway pressure (CPAP) therapy remains the gold standard in the treatment of moderate to severe obstructive sleep apnea. The CPAP device delivers a continuous stream of air through a mask, preventing airway collapse during sleep. The effectiveness of CPAP therapy has been confirmed by numerous studies:
- In patients with diabetes, CPAP therapy significantly reduces nighttime glycemic variability, which is an important indicator of glycemic control [6].
- CPAP therapy has a positive effect on autonomic nervous system dysfunction and alters the circadian pattern of heart rate variability in patients with sleep apnea and paroxysmal atrial fibrillation [8].
-
Lifestyle Changes
Lifestyle modification plays a key role, especially for patients with obesity, which is a frequent comorbidity in sleep apnea [1]. Weight loss can significantly reduce the severity of OSA. Other recommendations include avoiding alcohol and sedatives before bed, as well as changing sleeping position (e.g., sleeping on your side).
Innovative Approaches and New Horizons in Treatment
Scientific research continues to unlock new possibilities for treating sleep apnea, especially for those who cannot tolerate traditional CPAP therapy.
-
Hypoglossal Nerve Stimulation (HGNS)
Hypoglossal nerve stimulation (HGNS) implantation is becoming an increasingly common treatment for moderate to severe obstructive sleep apnea. This device stimulates the hypoglossal nerve, causing the tongue muscles to move forward and open the airway during sleep. Studies show that HGNS can be effective; however, obesity may be associated with a higher apnea-hypopnea index (AHI) and a lower likelihood of treatment success 6 months after implantation [5]. This highlights the importance of careful patient selection.
-
Incretin-Based Therapies
Incretin-based medications, such as semaglutide and tirzepatide, originally developed to treat type 2 diabetes and obesity, are demonstrating an expanded role in the management of obesity-related conditions, including obstructive sleep apnea. These therapies promote significant weight loss, which in turn can improve OSA status, especially in obese patients [7]. This direction opens up new prospects for comprehensive treatment.
Comprehensive Approach and Comorbidity Management
Effective treatment of snoring and sleep apnea requires a comprehensive approach that takes into account all comorbid conditions. Since OSA is often accompanied by obesity [1, 5], hypertension [2], diabetes [6], and cardiovascular diseases such as atrial fibrillation [8], it is important not only to treat the apnea itself, but also to manage these conditions. For example, nocturnal hypertension, which is a strong predictor of cardiovascular events, requires special attention [2].
An individualized treatment plan developed by a physician may include a combination of methods: from CPAP therapy and lifestyle changes to surgical interventions and innovative pharmacological approaches. Regular monitoring and adaptation of therapy to the changing needs of the patient are the key to long-term success.
Conclusion
The treatment of snoring and sleep apnea is constantly evolving, offering increasingly effective and personalized solutions. From time-tested CPAP therapy to innovative methods such as hypoglossal nerve stimulation and incretin-based medications, options for improving sleep quality and overall health are expanding. Early diagnosis and close cooperation with a somnologist allow for choosing the optimal strategy and significantly reducing the risks associated with this common disorder.
References
- [1] Clinical data on catatrenia: real-world practice analysis from a tertiary sleep center. (Pulmonology, 2026)
https://pubmed.ncbi.nlm.nih.gov/42609118/ - [2] Global prevalence of nocturnal hypertension: a systematic review and meta-analysis. (BMC public health, 2026)
https://pubmed.ncbi.nlm.nih.gov/42265642/ - [5] Outcomes of hypoglossal nerve stimulation implantation in obstructive sleep apnea patients with diverse health status. (Laryngoscope investigative otolaryngology, 2026)
https://pubmed.ncbi.nlm.nih.gov/42626066/ - [6] Obstructive sleep apnea and glycemic variability in individuals with diabetes: a systematic review and meta-analysis. (Journal of sleep research, 2026)
https://pubmed.ncbi.nlm.nih.gov/42213029/ - [7] From weight loss to organ-specific disease modification: a review of incretin-based therapies in obesity-related cardiometabolic diseases, chronic kidney disease, metabolic dysfunction-associated steatotic liver disease, and obstructive sleep apnea. (Cureus, 2026)
https://pubmed.ncbi.nlm.nih.gov/42559252/ - [8] Sleep apnea and paroxysmal atrial fibrillation: circadian pattern of autonomic dysfunction and the impact of CPAP therapy. (Journal of arrhythmia, 2026)
https://pubmed.ncbi.nlm.nih.gov/42281925/
The information provided in this article is for reference purposes only and does not replace professional medical advice. Always consult with a qualified healthcare provider for the diagnosis and treatment of any medical conditions.